Burzynski Research Institute, Inc.
| OTC Markets: BZYR
Burzynski Research Institute, Inc. is a biopharmaceutical company, which is engaged in the research and development facility of drugs that is being tested for the use in the treatment of cancer, and provides consulting services. It focuses on cancer treatment with two pipeline drugs-antineoplastons (ANP) in one Phase III clinical trial and 5 Phase II clinical trials. The company was founded by Stanislaw R. Burzynski in 1977 and is headquartered in Houston, TX.